Morning Briefing
Summaries of health policy coverage from major news organizations
Shipments Of J&J's Shot To States May Start Next Week
The Biden administration is planning to send states, pharmacies and community health centers 3 million to 4 million doses of Johnson & Johnson's coronavirus vaccine as early as next week, a White House official said Wednesday. (Weixel, 2/24)
"We are doing the work so if the EUA is granted we will waste no time in getting life-saving vaccines into the arms of Americans," said Jeff Zients, the Biden administration's COVID-19 czar during today’s press conference on response efforts. Zients said governors have received information about how to possibly distribute the Johnson & Johnson vaccine, which, unlike the current approved and in-use vaccines, requires only one shot and standard refrigeration. (Soucheray, 2/24)
The US is one step closer to having a third Covid-19 vaccine and it can't come soon enough. With people clamoring for a shot, it was welcome news that the US Food and Drug Administration's analysis Johnson & Johnson's trial data showed its vaccine is safe and effective. Here's what that could mean for you. (Christensen, 2/24)
The U.S. Food and Drug Administration is expected to grant emergency use authorization to Johnson & Johnson’s single-dose COVID-19 vaccine this week, a move that would ease the nationwide supply constraints and bring America one step closer to combating the coronavirus pandemic. Data suggests the vaccine, made by Johnson & Johnson’s Janssen Pharmaceutical Companies, is safe and effective, especially at preventing severe disease, scientists and medical experts say. (Miller and Cohn, 2/25)
